NCT04024527View on ClinicalTrials.gov

High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment

PHASE4CompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

July 25, 2019

Primary Completion Date

April 12, 2021

Study Completion Date

May 24, 2021

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Esomeprazole

Proton pump inhibitor

DRUG

Amoxicillin

Antibiotic for H. pylori eradication

DRUG

Metronidazole

Antibiotic for H. pylori eradication

Trial Locations (1)

200127

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT04024527 - High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment | Biotech Hunter | Biotech Hunter